HIIFS
RDY icon

Harel Insurance Investments & Financial Services’s Dr. Reddy's Laboratories RDY Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,000
Closed -$92K – 845
2020
Q4 		$92K Sell
2,000
-670
-25% -$9.02K ﹤0.01% 555
2020
Q3 		$37K Buy
+2,670
New +$31.8K ﹤0.01% 493
2016
Q3 		– Sell
-3,750
Closed -$38K – 628
2016
Q2 		$38K Buy
+3,750
New +$34.4K ﹤0.01% 381

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Harel Insurance Investments & Financial Services's RDY Position: Q1 2021 in Review

Harel Insurance Investments & Financial Services sold out of Dr. Reddy's Laboratories (RDY) in Q1 2021, closing a stake of 2,000 shares — an estimated $92K sold.

Harel Insurance Investments & Financial Services first reported a position in RDY in Q2 2016 and held it in 3 quarters. The position peaked at $92K in Q4 2020. 161 funds tracked by Wall St. Rank hold RDY as of Q1 2021.

  • Harel Insurance Investments & Financial Services reported no remaining Dr. Reddy's Laboratories position as of Q1 2021 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 2,000 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $92K.
  • Harel Insurance Investments & Financial Services first reported a position in Dr. Reddy's Laboratories in Q2 2016 and held it in 3 quarters.
  • Harel Insurance Investments & Financial Services's Dr. Reddy's Laboratories position peaked at $92K in Q4 2020.
  • 161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2021, filed 27 Apr 2021.